Charles Schwab Investment Management Inc. Purchases 6,370 Shares of Prestige Consumer Healthcare Inc. $PBH

Key Points

• Charles Schwab Investment Management Inc. has increased its stake in Prestige Consumer Healthcare Inc. by 1.0%, acquiring an additional 6,370 shares to reach a total of 642,390 shares, valued at approximately $55.2 million.
• The company's stock recently saw a modest increase of 0.7%, with a current market cap of $3.20 billion and significant institutional ownership at 99.95%.
• Prestige Consumer Healthcare reported a loss in Q2 earnings, with an EPS of $0.95, falling short of expectations, while revenue declined 6.6% year-over-year.

Charles Schwab Investment Management Inc. increased its position in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 1.0% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 642,390 shares of the company's stock after purchasing an additional 6,370 shares during the period. Charles Schwab Investment Management Inc. owned approximately 1.30% of Prestige Consumer Healthcare worth $55,226,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. Westwood Holdings Group Inc. lifted its holdings in shares of Prestige Consumer Healthcare by 7.1% in the 1st quarter. Westwood Holdings Group Inc. now owns 861,282 shares of the company's stock worth $74,044,000 after purchasing an additional 56,802 shares in the last quarter. Costello Asset Management INC bought a new position in shares of Prestige Consumer Healthcare in the 1st quarter worth $112,000. Blair William & Co. IL lifted its holdings in shares of Prestige Consumer Healthcare by 16.4% in the 1st quarter. Blair William & Co. IL now owns 106,114 shares of the company's stock worth $9,123,000 after purchasing an additional 14,967 shares in the last quarter. Jefferies Financial Group Inc. bought a new position in shares of Prestige Consumer Healthcare in the 1st quarter worth $203,000. Finally, Pacific Capital Partners Ltd bought a new position in shares of Prestige Consumer Healthcare in the 1st quarter worth $1,075,000. 99.95% of the stock is currently owned by institutional investors.

Prestige Consumer Healthcare Stock Performance

Shares of NYSE:PBH traded down $0.1860 during midday trading on Wednesday, reaching $65.2240. The company had a trading volume of 657,471 shares, compared to its average volume of 549,104. The company's 50 day moving average price is $76.03 and its 200 day moving average price is $81.31. The company has a current ratio of 4.38, a quick ratio of 2.99 and a debt-to-equity ratio of 0.55. The stock has a market cap of $3.21 billion, a P/E ratio of 15.31, a P/E/G ratio of 2.07 and a beta of 0.43. Prestige Consumer Healthcare Inc. has a 52-week low of $62.95 and a 52-week high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.95 earnings per share for the quarter, missing analysts' consensus estimates of $1.01 by ($0.06). The company had revenue of $249.53 million during the quarter, compared to analysts' expectations of $260.71 million. Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%.Prestige Consumer Healthcare's quarterly revenue was down 6.6% compared to the same quarter last year. During the same period last year, the firm posted $0.90 earnings per share. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.500-4.580 EPS. As a group, sell-side analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the company. Wall Street Zen cut Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a report on Saturday, August 9th. Royal Bank Of Canada raised shares of Prestige Consumer Healthcare to a "hold" rating in a report on Thursday, May 8th. Finally, Canaccord Genuity Group cut their price objective on shares of Prestige Consumer Healthcare from $105.00 to $100.00 and set a "buy" rating on the stock in a report on Friday, August 8th. Three analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $93.33.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.